Advances in KSHV Research: Molecular Pathogenesis, Immune Evasion, and Evolving Therapeutic Horizon
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70695 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Muhammad Waqas Nasir und 1 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. Hauptthemen laut MEDLINE: Herpesvirus 8, Human, Immune Evasion, Sarcoma, Kaposi. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 105 Literaturangaben. Gefördert von: This study was supported by Anhui Provincial Natural Science Foundation Project "In Vivo Induction and Regulation of Anti-HIV Broad-spectrum Neutralizing Antib….
Abstract (Originalsprache)
Kaposi's sarcoma–associated herpesvirus (KSHV/HHV‐8) infects more than 140 million people worldwide, with transmission occurring mainly through saliva, blood transfusion, and sexual contact. Despite its global burden, especially in HIV‐endemic regions, KSHV‐related diseases remain underdiagnosed and poorly managed. This review highlights current knowledge of KSHV pathogenesis with emphasis on latency, immune evasion, and oncogenesis. We summarize how viral proteins such as latency‐associated nuclear antigen (LANA) and viral interleukin‐6 (vIL‐6) manipulate host cell survival pathways, including PI3‐K signaling and Rho GTPase regulation, to drive Kaposi's sarcoma, multicentric Castleman disease, and primary effusion lymphoma. Advances in diagnostics (PCR, serology, immunohistochemistry) and targeted therapies, particularly rituximab, have improved patient outcomes, although treatment challenges remain. Ongoing efforts in vaccine development and immune‐based interventions hold promise for controlling viral persistence and preventing cancer progression. A deeper understanding of KSHV–host interactions will be crucial for designing next‐generation therapies and guiding future public health strategies. This review is framed as an update on recent advances in KSHV biology and therapeutic research. We distinguish between well‐established mechanisms and emerging hypotheses, highlighting how new discoveries in viral pathogenesis and host–virus interactions are reshaping potential therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
ORCID-Profile: Muhammad Waqas Nasir, Yong Gao
Förderung
- This study was supported by Anhui Provincial Natural Science Foundation Project "In Vivo Induction and Regulation of Anti-HIV Broad-spectrum Neutralizing Antib…
Zitieren
APA
Nasir, M. W., & Gao, Y. (2025). Advances in KSHV Research: Molecular Pathogenesis, Immune Evasion, and Evolving Therapeutic Horizon. Journal of Medical Virology. https://doi.org/10.1002/jmv.70695
Vancouver
Nasir MW, Gao Y. Advances in KSHV Research: Molecular Pathogenesis, Immune Evasion, and Evolving Therapeutic Horizon. Journal of Medical Virology. 2025. doi:10.1002/jmv.70695
BibTeX
@article{Nasir2025,
author = {Nasir, Muhammad Waqas and Gao, Yong},
title = {Advances in KSHV Research: Molecular Pathogenesis, Immune Evasion, and Evolving Therapeutic Horizon},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70695}
}
EUVIMED